Radisens is a market-led medical diagnostics company with the mission of offer patients test results for any condition, anywhere, instantly. Radisens targets the decentralized in-vitro diagnostics market including physicians’ offices, pharmacies, outpatient departments and community clinics. Healthcare systems worldwide struggle to cope with the increasing global chronic disease epidemic, which requires improved patient management in tandem with the relentless drive for improved healthcare efficiencies.
No solution on the market offers a single diagnostic platform integrating multiple high-sensitivity immunoassays, clinical chemistries and hematology (cell counting) assays at point-of-care….
Incumbent devices offer some blood tests, with many being qualitiative. However, myriad bespoke devices are required to offer even a limited decentralized service. Radisens fills this market need with instant laboratory-grade test results, requiring a fraction of a blood drop.